Hyaluronic acid (HA), a linear polysaccharide composed of alternating β-1,3-glucuronic acid (GlcA) and β-1,4-N-acetylglucosamine (GlcNAc) disaccharide units, is widely utilized in food, pharmaceutical, and cosmetic industries. Conventional in vitro HA biosynthesis is hindered by the reliance on costly nucleotide sugar precursors (UDP-GlcA and UDP-GlcNAc) and inefficient multienzyme coordination. To address these challenges, this study established a cell-free enzymatic cascade system integrating HA de novo synthesis with nucleotide recycling through eight pathway enzymes. By leveraging nucleotide sugar salvage pathways, UDP-GlcA and UDP-GlcNAc were efficiently synthesized from inexpensive monosaccharides, thereby bypassing energy-intensive de novo routes. Soluble expression of Pasteurella multocida hyaluronan synthase (PmHAS) was achieved by truncating its membrane-associated domains to enable sequential glycosyl transferase activity in aqueous systems. A dual ATP/UTP regeneration strategy was further implemented to sustain nucleotide supply, eliminating costly downstream purification. Under optimized conditions, the system produced 1.28 g/L HA within 24 h, with a molecular weight range of 1.28 × 10⁴to 1.02 × 10⁶Da and a substrate conversion yield of 65.9%. This work not only provides an economical platform for scalable HA synthesis but also establishes a modular enzymatic blueprint for engineering complex biopolymers, demonstrating broad applicability in synthetic glycobiology.